Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.64
Delayed Data
As of Jun 30
 0.00 / 0.00%
Today’s Change
0.62
Today|||52-Week Range
1.97
-37.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash----55.2M76.7M
 
 
 
Short Term Investment Cash25.0M34.4M-31.6M21.6M
 
 
 
 
 
Cash & Short Term Investments52.0M86.4M55.2M76.7M
 
 
 
 
 
 
ReceivablesReceivables1.4M2.1M1.9M0.00
 
 
 
 
 
InventoriesInventories4.0M8.0M6.7M5.8M
 
 
 
 
 
 
Current AssetsPrepaid Expenses251.0K286.0K369.0K408.0K
 
 
 
 
 
Other Current Assets3.3M1.2M1.4M3.0M
 
 
 
 
 
Current Assets61.1M97.9M65.5M85.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross31.1M32.0M32.7M33.5M
 
 
 
 
 
Depreciation-14.8M-18.3M-21.5M-23.8M
 
 
 
 
 
Other Assets1.3M1.7M1.7M1.6M
 
 
 
 
 
Total Assets78.7M113.3M78.5M97.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.3M5.3M4.0M3.6M
 
 
 
 
 
Accrued Expenses6.2M4.9M12.8M3.0M
 
 
 
 
 
Other Current Liabilities18.7M19.9M21.0M6.5M
 
 
 
 
 
Other Liabilities25.8M26.7M26.2M11.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0067.0M67.5M72.1M
 
 
 
 
Other Liabilities5.4M2.4M912.0K0.00
 
 
 
 
Total Liabilities82.1M140.3M134.1M86.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-3.4M-26.9M-55.6M10.9M
 
 
 
 
 
Total Shareholder Equity-3.4M-26.9M-55.6M10.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding93.5M93.6M93.6M99.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.